SubQ Testosterone Injections Explained for Patients

SubQ Testosterone Injections: A Scientific Chiropractic Look at a Simpler Hormone Route

By Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Abstract
Subcutaneous testosterone injections place hormone therapy in the fatty layer just under the skin instead of deep in a muscle. For many people who self-inject, this route can feel easier and keep blood levels more even throughout the week. This Chiropractic Scientist guide explains how the method works for men and, with extra caution and lab checks, how it is sometimes used in women. It also shows how testosterone supports muscle, bone, energy, and healing—and how integrative chiropractic care in El Paso can work with medical hormone care so mobility, flexibility, and agility improve together.

Why a Scientific Chiropractic Clinic Talks About the Needle

At Chiropractic Scientist, we study how the body moves and how its systems talk to each other. Hormones are chemical messengers. The spine, joints, and muscles are the frame those messengers have to work through.

When testosterone is low, people often feel weak, slow to recover, and less able to train. That shows up in the clinic as guarded hips, a stiff low back, weaker lift-off from a chair, and longer rehab after a sprain or crash. A hormone plan that a person dreads injecting does not help that picture. A plan they can keep doing might help.

For about eighty years, the default testosterone shot went deep into muscle. Newer pharmacokinetic work and real-world cohorts now make a quieter case: moving the same ester under the skin is not a weaker version of care. For many self-managing patients, it is the more livable default.

This post is educational. It is not a prescription, and it does not replace an exam, labs, or shared decision-making.

What a Subcutaneous Shot Is

A subcutaneous (SubQ) injection goes into the thin layer of fat under the skin. Common sites are the abdomen and the outer thigh. The needle is short and thin. An intramuscular (IM) shot goes deeper into muscle, often the glute or thigh, and usually requires a longer needle.

Both routes can use the same classic esters, such as testosterone cypionate or enanthate. The change is the depot. Fat has less blood flow than muscle, so the oil often releases the hormone more slowly. Average exposure can stay in a similar range. The weekly curve is often flatter.

That flatter curve is the key clinical point. Deep IM shots can create a high peak, then a sag before the next dose. People feel that sag as low energy, low mood, or a mid-cycle crash. SubQ dosing tends to trim those swings.

On this site, we already cover another subcutaneous option—hormone pellets placed under the skin for months at a time (Pellet Therapy: A Guide to Subcutaneous Hormones). Weekly or twice-weekly SubQ liquid injections are different.

• They use a home needle instead of an in-office implant.
• They are easier to raise or lower after an assessment.
• They are one more tool, not a replacement for every other tool.

What the Research Actually Shows

The Endocrine Society guideline tells clinicians to restore testosterone into the mid-normal range in men who truly need treatment, individualize the product, and monitor on a schedule. The route looks like a small detail in that list. In daily life, it is not. Route often decides whether a person is still injecting a year later.

A systematic review found comparable pharmacokinetics and mean serum levels with SubQ esters and called the route feasible, practical, and reasonable for routine use. A 52-week registration study of weekly SubQ enanthate reported that most men reached the target range and that more than 95% reported no injection-related pain. People who switched from IM to SubQ in other cohorts often preferred the shorter needle.

One dosing rule belongs in every conversion visit. A milligram under the skin may not equal a milligram in the muscle. After a switch, assess the level and the patient. Do not assume syringe-for-syringe equality.

Safety still follows the molecule and the blood level, not the needle length. Keep hematocrit, PSA when indicated, and symptom review on the same calendar. A gentler shot is not a lighter drug.

SubQ Testosterone for Men and for Women

Most of the cleanest SubQ data come from men with hypogonadism and from gender-affirming care. In those groups, SubQ shots have produced target-range levels across a wide body-mass range, with milder local reactions and a clear preference over IM when people compared both.

Women need a more careful approach. In the United States, no testosterone product is FDA-approved for women. When testosterone is used, it is considered off-label. The goal is a physiologic, premenopausal-range level—not a male dose. Randomized trials in women lean toward transdermal gels more than injections. Any SubQ plan in women should be individualized, written into the chart, and confirmed with labs so exposure stays in a safe female range.

That is the same standard we use across bioidentical hormone work on this site: match the messenger to the person, then prove the level. See also Integrative Medicine: What to Expect With HRT & Menopause and BHRT Diet Plan to Support Your Hormonal Therapy.

Why the Easier Needle Changes Follow-Through

If the pharmacokinetics are close, daily life breaks the tie.

• A short, fine needle into a pinch of belly or thigh fat is easier to learn at home.
• Pain and pre-shot dread are usually lower than with a deep muscle shot.
• There is no awkward reach to the glute and less concern about the sciatic path.
• Levels can stay steadier through the week.
• Cost can stay low because the same generic esters are used.
• There is no skin-to-skin transfer risk like gels and patches.

Needle fear is common. It makes people put a five-minute task off until tomorrow. Tomorrow is where long-term therapy frays.

SubQ is still an injection. It is “no needles.” For people who don’t want pellet placement and don’t want a deep IM ritual, a small home shot can be the middle path.

How the Home Shot Is Taught

A licensed clinician teaches the first doses. The usual steps are simple:

• Wash hands. Set out a clean syringe, a short needle (often 25- to 30-gauge and about half an inch), an alcohol wipe, and a sharps container.
• Choose a clean site on the abdomen or outer thigh. Rotate sites.
• Pinch a fold of skin. Insert the needle at about a 45-degree angle. Inject slowly.
• Do not share pens or syringes. Place used needles in a sharps box.

Xyosted is an FDA-cleared weekly auto-injector for men, used in the abdomen. Some practices use compounded syringes. The treating clinician still manages the dose, storage, and follow-up.

Testosterone, Muscle, Bone, and the Injury Patient

Testosterone helps the body keep lean muscle, support bone density, recover after strain, and hold energy and drive. When the level stays too low, rehab feels heavier. Stairs feel taller. A personal-injury patient who already guards a neck or low back now has less muscle to share the load.

That is why this topic belongs on a scientific chiropractic site. Weaker muscle changes joint mechanics. Slower tissue repair stretches the timeline after a T-bone crash, a fall, or a sports sprain. Sleep and mood often fall with the strength loss, and a tired nervous system holds tightness longer.

A steadier hormone curve does not replace an adjustment, a decompression plan, or a strength progression. It can give the tissue a clearer internal signal while those plans run.

Integrative Chiropractic Care: Structure Plus Signal

Hormone therapy works inside the body. Chiropractic care works on the frame that carries the body.

When the spine and pelvis are restricted, the muscles tighten to protect the body. Joints load on one side. The autonomic system stays loud. That mix can blunt the gains people hope to see from hormone care. Integrative chiropractic care aims to restore motion, ease muscle tightness, and improve how the body shares load.

In my clinical observations, patients often report easier hip and low-back mechanics once they receive treatment for spinal and pelvic restrictions alongside other therapies. I have also seen some men do better when large, infrequent depot shots are changed to smaller, more frequent SubQ doses. The mid-cycle crash—fatigue, irritability, a sense that “the shot wore off”—often settles when the curve flattens. Labs still decide the number. The person decides whether the week feels livable.

Mobility, flexibility, and agility are the clinic’s working goals. Hormone support may help the engine. Chiropractic and rehab help keep the chassis aligned so the engine can be used.

How the El Paso Team Puts This Together

Injury Medical Clinic PA is a multidisciplinary practice. I serve as clinical director as a chiropractor and board-certified family nurse practitioner. Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine (NPI #1164426749, Texas MD License #J2933). She has more than 40 years of experience as an internist and serves as medical director and collaborative physician.

That pairing is the point of an integrative injury and wellness clinic. Medical direction covers diagnostic support, internal medicine risk, and hormone monitoring. Chiropractic and rehabilitation cover alignment, soft tissue, personal injury recovery, and return to activity. Functional medicine adds labs, nutrition, sleep, and gut-muscle links so the plan is not a shot in isolation.

In practice, a person might move through:

• Medical review of symptoms, meds, fertility goals, and safety screens
• Targeted hormone and metabolic labs
• Chiropractic care for spinal and pelvic mechanics
• Rehab for strength, balance, and sport or work demand
• Nutrition and recovery habits that support hormone work
• Follow-up labs for testosterone, hematocrit, and PSA when indicated

Main East Side clinic: 11860 Vista Del Sol, Suite 128, El Paso, TX 79936. Office: 915-850-0900 or 915-412-6677.

Who This Option May Suit

SubQ testosterone may be worth a supervised discussion when:

• A person has a confirmed need for replacement or needs carefully monitored optimization and can learn to administer a home shot.
• IM shots cause pain, anxiety, or missed doses.
• Pellets feel like too much commitment or are difficult to fine-tune.
• Gels are messy or raise transfer concerns at home.
• The goal is a steadier week, not a bigger peak.

It is a poor first choice when fertility is an immediate goal, when there is a prostate or breast cancer concern, when hematocrit is already high, or when a woman needs a route with stronger female-specific trial data. Those calls belong in the clinic.

Clinical Take-Home for the Chiropractic Scientist Reader

1. Offer the easier route to people who will self-inject, then prove the level.
2. Counsel the flatter curve as a feature, not a loss of potency.
3. Recheck labs after any IM-to-SubQ switch.
4. Keep monitoring identical: exposure still drives hematocrit and other risks.
5. Treat the spine and the hormone plan as one system.
6. In women, confirm a physiologic female-range level and document why that route was chosen.

The quiet case for the subcutaneous needle is a route fact, not a brand fact. Same ester. Different depot. Comparable average levels for many patients. A week that is easier to live in. Pair that with scientific chiropractic care, and the goal isn’t just a better lab printout. The goal is a body that can still move.

This content is educational and evidence-informed. The FDA does not review compounded medicines in the same way it reviews approved branded products. The prescribing clinician makes final treatment decisions after a full evaluation.

References

Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744. https://doi.org/10.1210/jc.2018-00229

Cleveland Clinic. (n.d.). Subcutaneous testosterone injection.

Figueiredo, M. G., Gagliano-Jucá, T., & Basaria, S. (2022). Testosterone therapy with subcutaneous injections: A safe, practical, and reasonable option. The Journal of Clinical Endocrinology & Metabolism, 107(3), 614–626. https://doi.org/10.1210/clinem/dgab772

Hatzilabrou, T. A. (n.d.). The quiet case for the subcutaneous needle [White paper]. Worldborne Medical / Medivant Healthcare.

Jimenez, A. D. (n.d.). Clinical observations on hormone balance, subcutaneous dosing, and integrative chiropractic care. Chiropractic Scientist / Injury Medical Clinic PA.

Kaminetsky, J. C., McCullough, A., Hwang, K., Jaffe, J. S., Wang, C., & Swerdloff, R. S. (2019). A 52-week study of dose-adjusted subcutaneous testosterone enanthate in oil self-administered via disposable auto-injector. The Journal of Urology, 201(3), 587–594.

Mayo Clinic. (n.d.). Testosterone (intramuscular route, subcutaneous route).

Optimale. (2024). How to do a subcutaneous testosterone injection.

Spratt, D. I., Stewart, I. I., Savage, C., Craig, W., Spack, N. P., Chandler, D. W., Spratt, L. V., Eimicke, T., & Olshan, J. S. (2017). Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: Demonstration in female-to-male transgender patients. The Journal of Clinical Endocrinology & Metabolism, 102(7), 2349–2355.

Thimble Health. (n.d.). The hidden cost of needle fear: What healthcare systems overlook.